期刊文献+

3-溴丙酮酸对人肝癌HepG-2细胞增殖和凋亡的影响 被引量:4

THE EFFECTS OF 3-BROMOPYRUVATE ON THE PROLIFERATION AND APOPTOSIS IN HepG-2 CELL LINE
暂未订购
导出
摘要 目的:通过3-溴丙酮酸作用于HepG-2细胞,观察3-溴丙酮酸对HepG-2细胞增殖和凋亡的影响。方法:MTT法检测细胞增殖,倒置显微镜和透射电镜观察细胞形态,流式细胞术检测细胞周期分布和细胞凋亡。结果:3-溴丙酮酸在25~75μg/mL范围内,对HepG-2细胞的增殖具有明显的抑制作用并呈现剂量依赖性。3-溴丙酮酸处理HepG-2细胞后,倒置显微镜观察到细胞生长稀疏,细胞质透亮度下降,细胞脱落增多;透射电镜观察到染色质固缩、边集,核质内可见空泡。流式细胞术结果显示3-溴丙酮酸可将HepG-2细胞阻滞于S期,且DNA直方图上可见亚二倍体峰。在3.125~25μg/mL范围内,3-溴丙酮酸可剂量依赖性的诱导HepG-2细胞凋亡。结论:3-溴丙酮酸抑制HepG-2增殖并诱导HepG-2凋亡。 Objective:To investigate the effects of 3-bromopyruvate on the proliferation and apoptosis in HepG-2 Cells.Methods:Cell proliferation was assessed by MTT assay.The morphologic changes of HepG-2 cells were observed with convert light microscope and transmission electron microscope.The cell cycle distribution and apoptotic rate of HepG-2 cells were detected with flow cytometry.Results:The proliferation of HepG-2 cells was inhibited by 25~75 μg/mL 3-bromopyruvate in a dose-dependent manner.HepG-2 cells were treated with 3-bromopyruvate for 48h,convert light microscope showed cell growth was sparse,clarity of cytoplasm decreased and dead cells increased.Trasmission electron microscope showed that HepG-2 cell presented some morphologic features of apoptosis,including nuclear condensation and plasma membrane blebbing.HepG-2 Cell cycle progression was blocked by 3-bromopyruvate in the S pahse and apparent apoptotic peaks were observed.The concentoation of 3.125~25 g/ml 3-bromopyruvate can efficiently induce apoptosis of HepG-2 cells in a dose-dependent manner.Conclusion:3-bromopyruvate can efficiently inhibit the proliferation and induce apoptosis in HepG-2 cells.
机构地区 大连大学医学院
出处 《广西医科大学学报》 CAS 2010年第2期183-187,共5页 Journal of Guangxi Medical University
基金 辽宁省教育厅高校科研项目计划(2009T003)
关键词 肝细胞癌 3-溴丙酮酸 HEPG-2 细胞周期 hepatocellular carcinoma 3-Bromopyruvate HepG-2 cells cell cycle
  • 相关文献

参考文献10

  • 1Jean-Francois H,Geschwind,Ko YH,et al.Novel therapy for liver cancer:direct intraarterial injection of a potent inhibitor of ATP production[J].Cancer Res,2002,62(14):3 909-3 013.
  • 2Ko YH,Pedersen PL,Geschwind JF.Glucose catabolism in the rabbit VX2 tumor model for liver cancer:characterization and targeting hexokinase[J].Cancer Letters,2001,173(1):83-91.
  • 3Gwak GY,Yoon JH,Kim KM,et al.Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinaseⅡ expression[J].Journal of Hepatology,2005,42(3):358-364.
  • 4Josephina A Vossen,Manon Buijs,Labiq Syed,et al.Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model:effect on metastases after partial hepatectomy,intra-arterial treatment with 3-bromopyruvate and chemoembolization[J].Clin Exp Metastasis,2008,25(7):811-817.
  • 5Nelson K.3-Bromopyruvate kills cancer cells in animals[J].Lancet Oncol,2002,3(9):524.
  • 6Xu RH,Pelicano H,Zhou Y,et al.Inhibition of glycolysis in cancer cells:a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res,2005,65(2):613-621.
  • 7Won Kim,Jung Hwan Yoon,Jae Min Jeong,et al.Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma[J].Mol Cancer Ther,2007,6(9):2 554-2 562.
  • 8Zhao Chen,Hui Zhang,Weiqin Lu,et al.Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate[J].J Bioenerg Biomembr,2008,40(6):607-618.
  • 9Dang CV,Semenza GL.Oncogenic alterations of metabolism[J].Trends Biochem Sci,1999,24(2):68-72.
  • 10Spitz DR,Sim JE,Ridnour LA,et al.Glucose deprivation-induced oxidative stress in human tumor cells:a fundamental defect in metabolism?[J].Ann N Y Acad Sci,2000,899:349-362.

同被引文献28

  • 1Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203[J].J Clin Oncol, 2006, 24: 4620-4625.
  • 2De Paoli A, Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer New treatment perspectives[J].Tumori, 2004, 90: 373-378.
  • 3Gwak GY, Yoon JH, Kim KM, et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression[J].J Hepatol, 2005, 42: 358-364.
  • 4Vossen JA, Buijs M, Syed L, et al. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on meta stases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization[J].Clin Exp Metastasis, 2008, 25: 811-817.
  • 5Chen Z, Zhang H, Lu W, et al. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate[J].Biochim Biophys Acta, 2009, 1787: 553-560.
  • 6Kim W, Yoon JH, Jeong JM, et al. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma[J].Mol Cancer Ther, 2007, 6: 2554-2562.
  • 7Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res, 2005, 65: 613-621.
  • 8Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production[J].Cancer Res, 2002, 62: 3909-3913.
  • 9Vali M, Liapi E, Kowalski J, et al. Intraarterial therapy with a new potent inhibitor of tumor metabolism(3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer[J].J Vasc Interv Radiol, 2007, 18: 95-101.
  • 10Li Chen,Guo-Sheng Ren,Fan Li,Shan-Quan Sun.Expression of Livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma[J].World Journal of Gastroenterology,2008,14(37):5749-5754. 被引量:41

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部